{"log_id": 5966002539729815811, "direction": 0, "words_result_num": 29, "words_result": [{"probability": {"variance": 7.8e-05, "average": 0.995009, "min": 0.971445}, "location": {"width": 209, "top": 246, "height": 28, "left": 261}, "words": "本品仅限于单独给药"}, {"probability": {"variance": 1e-06, "average": 0.999146, "min": 0.997096}, "location": {"width": 141, "top": 290, "height": 27, "left": 301}, "words": "静脉配伍溶剂"}, {"probability": {"variance": 0.001591, "average": 0.988194, "min": 0.790797}, "location": {"width": 560, "top": 330, "height": 35, "left": 260}, "words": "本品能与0.9%氯化钠注射液及乳酸钠林格注射液配伍使用"}, {"probability": {"variance": 0.001223, "average": 0.979659, "min": 0.902023}, "location": {"width": 149, "top": 380, "height": 26, "left": 265}, "words": "7、不相溶性"}, {"probability": {"variance": 1.7e-05, "average": 0.998658, "min": 0.982736}, "location": {"width": 365, "top": 421, "height": 33, "left": 261}, "words": "本品不能与含葡萄糖注射液配伍使用"}, {"probability": {"variance": 0.003316, "average": 0.972508, "min": 0.749542}, "location": {"width": 740, "top": 461, "height": 37, "left": 260}, "words": "本品不能用 Readymed人工橡胶注射泵给药。在本品贮存于 Readymed人"}, {"probability": {"variance": 0.001901, "average": 0.989564, "min": 0.737212}, "location": {"width": 789, "top": 505, "height": 38, "left": 215}, "words": "工橡胶注射泵的溶液稳定性研究中,鉴定出一个杂质(2-巯基苯并噻唑)能从"}, {"probability": {"variance": 1e-06, "average": 0.999316, "min": 0.997382}, "location": {"width": 206, "top": 557, "height": 28, "left": 217}, "words": "注射泵过滤至药液中"}, {"probability": {"variance": 0.001861, "average": 0.989747, "min": 0.741037}, "location": {"width": 786, "top": 588, "height": 36, "left": 216}, "words": "因为本品与其他的注射物质可联合使用的数据有限,所以不得在本品单瓶中或配"}, {"probability": {"variance": 0.000549, "average": 0.99196, "min": 0.878289}, "location": {"width": 786, "top": 633, "height": 35, "left": 216}, "words": "伍袋中添加任何物质,也不要使用同一条静脉输液线。如果需要使用同一条静脉"}, {"probability": {"variance": 0.000102, "average": 0.996818, "min": 0.94068}, "location": {"width": 785, "top": 679, "height": 31, "left": 217}, "words": "输液线连续给予不同药物时,在使用本品前或后,必须用相容的静脉注射溶剂冲"}, {"probability": {"variance": 0, "average": 0.997293, "min": 0.997293}, "location": {"width": 25, "top": 730, "height": 25, "left": 217}, "words": "洗"}, {"probability": {"variance": 0.000513, "average": 0.986167, "min": 0.937765}, "location": {"width": 128, "top": 779, "height": 28, "left": 223}, "words": "【不良反应】"}, {"probability": {"variance": 0.007928, "average": 0.974341, "min": 0.526348}, "location": {"width": 739, "top": 819, "height": 34, "left": 264}, "words": "以下对本品的速发过敏反应/超敏反应、肌病和横纹肌溶解、嗜酸粒細胞性"}, {"probability": {"variance": 0.000491, "average": 0.989548, "min": 0.898231}, "location": {"width": 790, "top": 862, "height": 36, "left": 217}, "words": "肺炎、周围神经病变、国际标准化比值(INR)升高/凝血酶原时间延长等不良反应"}, {"probability": {"variance": 0.008039, "average": 0.966801, "min": 0.599042}, "location": {"width": 616, "top": 907, "height": 35, "left": 217}, "words": "进行了描述,更多描述见【注意事项】、【药物相互作用】等项"}, {"probability": {"variance": 8e-06, "average": 0.998175, "min": 0.989527}, "location": {"width": 744, "top": 945, "height": 33, "left": 264}, "words": "由于临床试验是在各种不同的情况下进行的,一种药物在临床试验中观察到"}, {"probability": {"variance": 4.7e-05, "average": 0.998195, "min": 0.959306}, "location": {"width": 831, "top": 989, "height": 36, "left": 217}, "words": "的不良反应发生率不能直接与其他的药物临床试验中观察到的不良反应发生率"}, {"probability": {"variance": 1e-06, "average": 0.99942, "min": 0.994751}, "location": {"width": 667, "top": 1032, "height": 36, "left": 217}, "words": "进行比较,且未必能反映实际医疗情况下观察到的不良反应发生率"}, {"probability": {"variance": 3.4e-05, "average": 0.995841, "min": 0.981369}, "location": {"width": 198, "top": 1083, "height": 27, "left": 265}, "words": "1、临床试验的经验"}, {"probability": {"variance": 0.000139, "average": 0.995193, "min": 0.930556}, "location": {"width": 742, "top": 1122, "height": 36, "left": 265}, "words": "本品临床试验中入组的1,864名患者接受本品的治疗,1,416名患者接受对"}, {"probability": {"variance": 3.9e-05, "average": 0.996763, "min": 0.984246}, "location": {"width": 115, "top": 1173, "height": 27, "left": 219}, "words": "照药的治疗"}, {"probability": {"variance": 0.000545, "average": 0.989336, "min": 0.908003}, "location": {"width": 339, "top": 1216, "height": 30, "left": 284}, "words": "1)复杂性皮肤及软组织感染试验"}, {"probability": {"variance": 0.008969, "average": 0.967558, "min": 0.509927}, "location": {"width": 745, "top": 1258, "height": 33, "left": 267}, "words": "在复杂性皮肤及软组织感染( CSSSI)Ⅲ期临床试验中,本品治疗组有15/534"}, {"probability": {"variance": 0.00023, "average": 0.993266, "min": 0.911017}, "location": {"width": 778, "top": 1302, "height": 33, "left": 231}, "words": "(2.8%)例患者因不良反应而中止用药,而对照组有17/558(3.0%)例患者因"}, {"probability": {"variance": 6e-06, "average": 0.998193, "min": 0.992962}, "location": {"width": 210, "top": 1350, "height": 28, "left": 221}, "words": "不良反应而中止用药"}, {"probability": {"variance": 0.000699, "average": 0.991655, "min": 0.847749}, "location": {"width": 735, "top": 1390, "height": 36, "left": 267}, "words": "按身体各系统, CSSSI(本品4mg/kg)试验中患者最常见的不良反应见表2"}, {"probability": {"variance": 0.001243, "average": 0.982848, "min": 0.869364}, "location": {"width": 432, "top": 1438, "height": 28, "left": 401}, "words": "表2.本品 ACSSSI期试验中发生率在2%以上"}, {"probability": {"variance": 9.4e-05, "average": 0.995205, "min": 0.963935}, "location": {"width": 273, "top": 1483, "height": 29, "left": 481}, "words": "且不小于对照组的不良反应"}], "language": 3}